WAP
TMO icon

Wealthcare Advisory Partners’s Thermo Fisher Scientific TMO Stock Holding History

Wealthcare Advisory Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$659K Sell
1,315
-1,391
-51% -$668K 0.01% 631
2026
Q1 		$1.33M Buy
2,706
+299
+12% +$162K 0.03% 448
2025
Q4 		$1.4M Buy
2,407
+61
+3% +$34.5K 0.03% 434
2025
Q3 		$1.14M Buy
2,346
+96
+4% +$44.7K 0.02% 464
2025
Q2 		$912K Sell
2,250
-188
-8% -$78.6K 0.02% 502
2025
Q1 		$1.21M Sell
2,438
-2,668
-52% -$1.44M 0.03% 404
2024
Q4 		$2.66M Sell
5,106
-85
-2% -$46.7K 0.07% 218
2024
Q3 		$3.21M Sell
5,191
-53
-1% -$31.4K 0.09% 192
2024
Q2 		$2.9M Sell
5,244
-90
-2% -$51.6K 0.09% 181
2024
Q1 		$3.1M Buy
5,334
+4,172
+359% +$2.34M 0.1% 168
2023
Q4 		$617K Sell
1,162
-72
-6% -$34.9K 0.02% 442
2023
Q3 		$624K Sell
1,234
-73
-6% -$38.9K 0.03% 378
2023
Q2 		$682K Sell
1,307
-9
-0.7% -$4.86K 0.03% 376
2023
Q1 		$759K Buy
1,316
+59
+5% +$33.3K 0.03% 354
2022
Q4 		$692K Buy
1,257
+179
+17% +$94.8K 0.03% 344
2022
Q3 		$547K Buy
1,078
+295
+38% +$165K 0.03% 342
2022
Q2 		$426K Buy
783
+101
+15% +$55.6K 0.03% 357
2022
Q1 		$403K Buy
682
+26
+4% +$14.9K 0.02% 350
2021
Q4 		$438K Buy
656
+38
+6% +$23.7K 0.03% 340
2021
Q3 		$353K Buy
618
+67
+12% +$36.8K 0.02% 375
2021
Q2 		$278K Buy
551
+22
+4% +$10.4K 0.02% 441
2021
Q1 		$242K Buy
+529
New +$252K 0.02% 445
2020
Q2 		– Sell
-209
Closed -$59K – 1251
2020
Q1 		$59K Sell
209
-44
-17% -$13.9K 0.01% 478
2019
Q4 		$82K Sell
253
-14
-5% -$4.25K 0.01% 441
2019
Q3 		$78K Sell
267
-14
-5% -$4.01K 0.01% 444
2019
Q2 		$83K Buy
281
+14
+5% +$3.86K 0.01% 418
2019
Q1 		$73K Buy
267
+79
+42% +$19.7K 0.01% 400
2018
Q4 		$42K Hold
188
– – 0.01% 468
2018
Q3 		$46K Hold
188
– – 0.01% 488
2018
Q2 		$39K Buy
188
+47
+33% +$9.98K 0.01% 517
2018
Q1 		$29K Sell
141
-97
-41% -$20.4K 0.01% 518
2017
Q4 		$45K Buy
238
+132
+125% +$25.3K 0.01% 391
2017
Q3 		$20K Buy
+106
New +$19.2K 0.01% 431

Other funds holding TMO

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Wealthcare Advisory Partners's TMO Position: Q2 2026 in Review

Wealthcare Advisory Partners reduced its Thermo Fisher Scientific (TMO) stake by 51% in Q2 2026, selling an estimated $668K and leaving 1,315 shares worth $659K. The position accounts for 0.01% of the portfolio, ranked #631.

Wealthcare Advisory Partners first reported a position in TMO in Q3 2017 and has held it in 33 quarters since. The position peaked at $3.21M in Q3 2024. 672 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Wealthcare Advisory Partners held 1,315 shares of Thermo Fisher Scientific worth $659K as of Q2 2026.
  • Wealthcare Advisory Partners sold 1,391 Thermo Fisher Scientific shares in Q2 2026, an estimated $668K.
  • Thermo Fisher Scientific made up 0.01% of Wealthcare Advisory Partners's portfolio in Q2 2026, its #631 holding.
  • Wealthcare Advisory Partners first reported a position in Thermo Fisher Scientific in Q3 2017 and has held it in 33 quarters since.
  • Wealthcare Advisory Partners's Thermo Fisher Scientific position peaked at $3.21M in Q3 2024.
  • 672 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2026, filed 9 Jul 2026.